<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD04640000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P35462</UniProt_ID>
  <Seq_Length>400</Seq_Length>
  <Molecule_Weight>44225</Molecule_Weight>
  <KEGG_ID>hsa:1814</KEGG_ID>
  <Orthology_ID>K04146</Orthology_ID>
  <Function_Summary>Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase. Promotes cell proliferation.</Function_Summary>
  <Pfam_ID>PF00001:7tm_1</Pfam_ID>
  <Allosteric_Activator_Count>12</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>1</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Dopamine D3 receptor</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Combining with an extracellular or intracellular messenger to initiate a change in cell activity.</Detail>
      <Keyword>Receptor activity</Keyword>
      <Ontology_ID>GO:0004872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with the neurotransmitter dopamine and activating adenylate cyclase via coupling to Gi/Go to initiate a change in cell activity.</Detail>
      <Keyword>Dopamine receptor activity, coupled via Gi/Go</Keyword>
      <Ontology_ID>GO:0001591</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.</Detail>
      <Keyword>Drug binding</Keyword>
      <Ontology_ID>GO:0008144</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>9</Position>
      <Original>Ser</Original>
      <Variation>Gly</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal, e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light, and ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell, and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.</Detail>
      <Keyword>Signal transduction</Keyword>
      <Ontology_ID>GO:0007165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which a startle magnitude is reduced when the startling stimulus is preceded by a low-intensity prepulse.</Detail>
      <Keyword>Prepulse inhibition</Keyword>
      <Ontology_ID>GO:0060134</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.</Detail>
      <Keyword>G-protein coupled receptor protein signaling pathway</Keyword>
      <Ontology_ID>GO:0007186</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.</Detail>
      <Keyword>Response to drug</Keyword>
      <Ontology_ID>GO:0042493</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of gene expression such that an expression pattern recurs with a regularity of approximately 24 hours.</Detail>
      <Keyword>Circadian regulation of gene expression</Keyword>
      <Ontology_ID>GO:0032922</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process in an organism in which a change in behavior of an individual occurs in response to repeated exposure to a visual cue.</Detail>
      <Keyword>Visual learning</Keyword>
      <Ontology_ID>GO:0008542</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of mitosis.</Detail>
      <Keyword>Positive regulation of mitosis</Keyword>
      <Ontology_ID>GO:0045840</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in the behavior of an organism as a result of a cocaine stimulus.</Detail>
      <Keyword>Behavioral response to cocaine</Keyword>
      <Ontology_ID>GO:0048148</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a dopamine receptor binding to its physiological ligand, followed by activation of adenylyl cyclase and a subsequent increase in the concentration of cyclic AMP.</Detail>
      <Keyword>Activation of adenylate cyclase activity by dopamine receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0007191</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process in which the force of blood traveling through the circulatory system is decreased.</Detail>
      <Keyword>Negative regulation of blood pressure</Keyword>
      <Ontology_ID>GO:0045776</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of oligodendrocyte differentiation.</Detail>
      <Keyword>Negative regulation of oligodendrocyte differentiation</Keyword>
      <Ontology_ID>GO:0048715</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the dopamine receptor protein signaling pathway. A dopamine receptor signaling pathway is the series of molecular signals generated as a consequence of a dopamine receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Positive regulation of dopamine receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0060161</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a dopamine receptor binding to its physiological ligand, followed by inhibition of adenylyl cyclase and a subsequent decrease in the concentration of cyclic AMP.</Detail>
      <Keyword>Inhibition of adenylate cyclase activity by dopamine receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0007195</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Behavior that occurs predominantly, or only, in individuals that are part of a group.</Detail>
      <Keyword>Social behavior</Keyword>
      <Ontology_ID>GO:0035176</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the regulated release of dopamine.</Detail>
      <Keyword>Regulation of dopamine secretion</Keyword>
      <Ontology_ID>GO:0014059</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The specific movement from place to place of an organism in response to external or internal stimuli. Locomotion of a whole organism in a manner dependent upon some combination of that organism's internal state and external conditions.</Detail>
      <Keyword>Locomotory behavior</Keyword>
      <Ontology_ID>GO:0007626</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process involved in the maintenance of an internal steady state of calcium ions at the level of a cell.</Detail>
      <Keyword>Cellular calcium ion homeostasis</Keyword>
      <Ontology_ID>GO:0006874</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a histamine stimulus. Histamine, the biogenic amine 2-(1H-imidazol-4-yl)ethanamine, is involved in local immune responses as well as regulating physiological function in the gut and acting as a neurotransmitter.</Detail>
      <Keyword>Response to histamine</Keyword>
      <Ontology_ID>GO:0034776</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process that results in the uptake of a G-protein coupled receptor into an endocytic vesicle.</Detail>
      <Keyword>G-protein coupled receptor internalization</Keyword>
      <Ontology_ID>GO:0002031</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of the controlled release of a protein from a cell or group of cells.</Detail>
      <Keyword>Negative regulation of protein secretion</Keyword>
      <Ontology_ID>GO:0050709</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the directed movement of the catecholamine neurotransmitter dopamine into a cell.</Detail>
      <Keyword>Regulation of dopamine uptake</Keyword>
      <Ontology_ID>GO:0051584</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving dopamine, a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline.</Detail>
      <Keyword>Dopamine metabolic process</Keyword>
      <Ontology_ID>GO:0042417</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a morphine stimulus. Morphine is an opioid alkaloid, isolated from opium, with a complex ring structure.</Detail>
      <Keyword>Response to morphine</Keyword>
      <Ontology_ID>GO:0043278</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Involuntary movement caused by the application of a stimulus to an organism and a subsequent movement. The signal processing of this movement takes place in the spinal cord.</Detail>
      <Keyword>Musculoskeletal movement, spinal reflex action</Keyword>
      <Ontology_ID>GO:0050883</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The controlled release of arachidonic acid from a cell or group of cells.</Detail>
      <Keyword>Arachidonic acid secretion</Keyword>
      <Ontology_ID>GO:0050482</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of the protein kinase B signaling cascade, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.</Detail>
      <Keyword>Negative regulation of protein kinase B signaling cascade</Keyword>
      <Ontology_ID>GO:0051898</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <molStructure/>
  <Molecule_Seq>
    <Protein_Seq>MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC</Protein_Seq>
    <DNA_Seq>GATAGAGAGACAAAGAGGAAAAGAGAGCGAGGTAGAAAACGGATACTGCCTATGCCTACTCCATCCCTCTTTCAGCACCAAGGACAGAACCTCTGAGCGGCTGACCCAAGCAACGCTCAGTTTAGGGTCCCTCCCAAATCCTCTAAAGAAAACGGATACATTCGAAAGCAGCTATGAAACATGCACTAAGGTCTAATAGGGAAGCTGGAAAAGCAGCACTCAAGTAATTTCACCTTAGAGGCAAAAATGGGTGATTTCTTTCTGTTCATTTCATAGTTTCTGAGTCCTGAGAAAGGCAAAGTTTGCTTTGCTTGGGTATGTCTGCTGTCAGTAAATGGCTGCAGGAGCCGAAGTGGTAAACTCCTCGGTCTCCAGAAATCAGAAGAAAATTTTAGGGAAGCCCCTTGGCATCACGCACCTCCCTCTGGGCTATGGCATCTCTGAGCCAGCTGAGTGGCCACCTGAACTACACCTGTGGGGCAGAGAACTCCACAGGTGCCAGCCAGGCCCGCCCACATGCCTACTATGCCCTCTCCTACTGCGCGCTCATCCTGGCCATCGTCTTCGGCAATGGCCTGGTGTGCATGGCTGTGCTGAAGGAGCGGGCCCTGCAGACTACCACCAACTACTTAGTAGTGAGCCTGGCTGTGGCAGACTTGCTGGTGGCCACCTTGGTGATGCCCTGGGTGGTATACCTGGAGGTGACAGGTGGAGTCTGGAATTTCAGCCGCATTTGCTGTGATGTTTTTGTCACCCTGGATGTCATGATGTGTACAGCCAGCATCCTTAATCTCTGTGCCATCAGCATAGACAGGTACACTGCAGTGGTCATGCCCGTTCACTACCAGCATGGCACGGGACAGAGCTCCTGTCGGCGCGTGGCCCTCATGATCACGGCCGTCTGGGTACTGGCCTTTGCTGTGTCCTGCCCTCTTCTGTTTGGCTTTAATACCACAGGGGACCCCACTGTCTGCTCCATCTCCAACCCTGATTTTGTCATCTACTCTTCAGTGGTGTCCTTCTACCTGCCCTTTGGAGTGACTGTCCTTGTCTATGCCAGAATCTATGTGGTGCTGAAACAAAGGAGACGGAAAAGGATCCTCACTCGACAGAACAGTCAGTGCAACAGTGTCAGGCCTGGCTTCCCCCAGCAAACCCTCTCTCCTGACCCGGCACATCTGGAGCTGAAGCGTTACTACAGCATCTGCCAGGACACTGCCTTGGGTGGACCAGGCTTCCAAGAAAGAGGAGGAGAGTTGAAAAGAGAGGAGAAGACTCGGAATTCCCTGAGTCCCACCATAGCGCCCAAGCTCAGCTTAGAAGTTCGAAAACTCAGCAATGGCAGATTATCGACATCTTTGAAGCTGGGGCCCCTGCAACCTCGGGGAGTGCCACTTCGGGAGAAGAAGGCAACCCAAATGGTGGCCATTGTGCTTGGGGCCTTCATTGTCTGCTGGCTGCCCTTCTTCTTGACCCATGTTCTCAATACCCACTGCCAGACATGCCACGTGTCCCCAGAGCTTTACAGTGCCACGACATGGCTGGGCTACGTGAATAGCGCCCTCAACCCTGTGATCTATACCACCTTCAATATCGAGTTCCGGAAAGCCTTCCTCAAGATCCTGTCTTGCTGAGGGAGC</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Brain</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to membrane</CellLocal>
      <Ontology_ID>GO:0016021</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Plasma membrane</CellLocal>
      <Ontology_ID>GO:0005886</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to plasma membrane</CellLocal>
      <Ontology_ID>GO:0005887</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>DRD3</Gene_Name>
    <Gene_ID>1814</Gene_ID>
    <Genbank_ACCN>NM_000796</Genbank_ACCN>
    <Protein_ACCN>NP_000787</Protein_ACCN>
    <HGNC_ID>3024</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/1814</Gene_URL>
    <UCSC_ID>uc003ebc.1</UCSC_ID>
    <EMBL_ID>ENSG00000151577</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Pathological Gambling</Disease_Name>
      <Disease_Detail>Pathological Gambling</Disease_Detail>
      <Disease_DB>PTH002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pathological_gambling?search=DRD3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Alcohol Dependence</Disease_Name>
      <Disease_Detail>Alcohol Dependence</Disease_Detail>
      <Disease_DB>ALC007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/alcohol_dependence?search=DRD3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Schizophrenia</Disease_Name>
      <Disease_Detail>Schizophrenia</Disease_Detail>
      <Disease_DB>SCH015</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/schizophrenia?search=DRD3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Tardive Dyskinesia</Disease_Name>
      <Disease_Detail>Tardive Dyskinesia</Disease_Detail>
      <Disease_DB>TRD006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tardive_dyskinesia?search=DRD3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cocaine Dependence</Disease_Name>
      <Disease_Detail>Cocaine Dependence</Disease_Detail>
      <Disease_DB>CCN001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cocaine_dependence?search=DRD3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Drug Dependence</Disease_Name>
      <Disease_Detail>Drug Dependence</Disease_Detail>
      <Disease_DB>DRG003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/drug_dependence?search=DRD3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Schizoaffective Disorder</Disease_Name>
      <Disease_Detail>Schizoaffective Disorder</Disease_Detail>
      <Disease_DB>SCH012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/schizoaffective_disorder?search=DRD3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Migraine Without Aura</Disease_Name>
      <Disease_Detail>Migraine</Disease_Detail>
      <Disease_DB>MGR001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/migraine_without_aura?search=DRD3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Opiate Dependence</Disease_Name>
      <Disease_Detail>Opiate Dependence</Disease_Detail>
      <Disease_DB>OPT003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/opiate_dependence?search=DRD3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Tremor</Disease_Name>
      <Disease_Detail>Tremor</Disease_Detail>
      <Disease_DB>TRM003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tremor?search=DRD3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Substance Dependence</Disease_Name>
      <Disease_Detail>Substance Dependence</Disease_Detail>
      <Disease_DB>SBS004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/substance_dependence?search=DRD3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Alcohol Abuse</Disease_Name>
      <Disease_Detail>Alcohol Abuse</Disease_Detail>
      <Disease_DB>ALC004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/alcohol_abuse?search=DRD3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Obsessive-Compulsive Personality Disorder</Disease_Name>
      <Disease_Detail>Obsessive-Compulsive Disorder</Disease_Detail>
      <Disease_DB>OBS003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/obsessive_compulsive_personality_disorder?search=DRD3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Bipolar Disorder</Disease_Name>
      <Disease_Detail>Bipolar Disorder</Disease_Detail>
      <Disease_DB>BPL003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/bipolar_disorder?search=DRD3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Essential Tremor</Disease_Name>
      <Disease_Detail>Essential Tremor</Disease_Detail>
      <Disease_DB>ESS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/essential_tremor?search=DRD3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Parkinson's Disease</Disease_Name>
      <Disease_Detail>Parkinson's Disease</Disease_Detail>
      <Disease_DB>PRK002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/parkinsons_disease?search=DRD3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Delusional Disorder</Disease_Name>
      <Disease_Detail>Delusional Disorder</Disease_Detail>
      <Disease_DB>DLS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/delusional_disorder?search=DRD3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Drug Addiction</Disease_Name>
      <Disease_Detail>Drug Addiction</Disease_Detail>
      <Disease_DB>DRG011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/drug_addiction?search=DRD3#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Structure of the human dopamine D3 receptor in complex with eticlopride</PDB_Title>
      <PDB_ID>3PBL</PDB_ID>
      <Resolution>2.89</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3PBL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the human dopamine d3 receptor in complex with a d2/d3 selective antagonist.</PubMed_Title>
      <Author>Chien, E.Y., et al.</Author>
      <Journal>Science(2010)330:1091-1095</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21097933?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD04640001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04640002</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04640003</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04640004</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04640005</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04640006</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04640007</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04640008</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04640009</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04640010</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04640011</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04640012</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04640013</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>